The miR-143/145 Cluster, a Novel Diagnostic Biomarker in Chondrosarcoma, Acts as a Tumor Suppressor and Directly Inhibits Fascin-1
Open Access
- 6 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 35 (6) , 1077-1091
Abstract
Chondrosarcoma is the second most frequent bone sarcoma. Due to the inherent chemo‐ and radiotherapy resistance and absence of known therapeutic targets, clinical management is limited to surgical resection. Consequently, patients with advanced disease face a poor prognosis. Hence, elucidating regulatory networks governing chondrosarcoma pathogenesis is vital for development of effective therapeutic strategies. Here, miRNA and mRNA next generation sequencing of different subtypes of human chondrogenic tumors in combination with in silico bioinformatics tools were performed with the aim to identify key molecular factors. We identified miR‐143/145 cluster levels to inversely correlate with tumor grade. This deregulation was echoed in the miRNA plasma levels of patients and we provided the first evidence that circulating miR‐145 is a potential non‐invasive diagnostic biomarker and can be valuable as an indicator to improve the currently challenging diagnosis of cartilaginous bone tumors. Additionally, artificial upregulation of both miRNAs impelled a potent tumor suppressor effect in vitro and in vivo in an orthotopic xenograft mouse model. A combined in silico/sequencing approach revealed FSCN1 as a direct target of miR‐143/145, and its depletion phenotypically resembled miR‐143/145 upregulation in vitro. Lastly, FSCN1 is a malignancy promoting factor associated with aggressive chondrosarcoma progression. Our findings underscore miR‐143/145/FSCN1 as important players in chondrosarcoma and may potentially open new avenues for specific therapeutic intervention options.Keywords
Funding Information
- Highly Specialized Medicine for Musculoskeletal Oncology program of the Canton of Zurich
- Schweizerischer Verein Balgrist
- University of Zurich
- Walter L. & Johanna Wolf Foundation
- Universität Zürich
This publication has 58 references indexed in Scilit:
- Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcomaNature Genetics, 2013
- Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysisBMC Medicine, 2013
- Large scale chromosomal mapping of human microRNA structural clustersNucleic Acids Research, 2013
- Regulation of Human Chondrocyte Function through Direct Inhibition of Cartilage Master Regulator SOX9 by MicroRNA-145 (miRNA-145)Journal of Biological Chemistry, 2012
- Proinvasion Metastasis Drivers in Early-Stage Melanoma Are OncogenesCancer Cell, 2011
- Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathwayGenes & Development, 2010
- Migrastatin analogues target fascin to block tumour metastasisNature, 2010
- MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1Cancer Research, 2010
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998